Cargando…

Targeted Therapy in Leukaemia, Lymphoma and Myeloma

Detalles Bibliográficos
Autor principal: Opat, Stephen Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781269/
https://www.ncbi.nlm.nih.gov/pubmed/35055389
http://dx.doi.org/10.3390/jpm12010074
_version_ 1784638049901084672
author Opat, Stephen Samuel
author_facet Opat, Stephen Samuel
author_sort Opat, Stephen Samuel
collection PubMed
description
format Online
Article
Text
id pubmed-8781269
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87812692022-01-22 Targeted Therapy in Leukaemia, Lymphoma and Myeloma Opat, Stephen Samuel J Pers Med Editorial MDPI 2022-01-08 /pmc/articles/PMC8781269/ /pubmed/35055389 http://dx.doi.org/10.3390/jpm12010074 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Opat, Stephen Samuel
Targeted Therapy in Leukaemia, Lymphoma and Myeloma
title Targeted Therapy in Leukaemia, Lymphoma and Myeloma
title_full Targeted Therapy in Leukaemia, Lymphoma and Myeloma
title_fullStr Targeted Therapy in Leukaemia, Lymphoma and Myeloma
title_full_unstemmed Targeted Therapy in Leukaemia, Lymphoma and Myeloma
title_short Targeted Therapy in Leukaemia, Lymphoma and Myeloma
title_sort targeted therapy in leukaemia, lymphoma and myeloma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781269/
https://www.ncbi.nlm.nih.gov/pubmed/35055389
http://dx.doi.org/10.3390/jpm12010074
work_keys_str_mv AT opatstephensamuel targetedtherapyinleukaemialymphomaandmyeloma